Mission Therapeutics launches clinical trial for kidney disease therapy
31st March 2022 Uncategorised 0MTX652 has advanced through preclinical regulatory toxicology studies and is ready for a phase 1 trial
More: Mission Therapeutics launches clinical trial for kidney disease therapy
Source: News